Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chantiya Chanswangphuwana"'
Autor:
Ran Reshef, Stephan A. Grupp, Janna Baez, Carrie L. Kitko, Paibel Aguayo-Hiraldo, Gregory A. Yanik, Aaron Etra, Yi-Bin Chen, Ryotaro Nakamura, Rachel Young, Muna Qayed, Steven Kowalyk, Umut Ozbek, Tal Schechter, William J. Hogan, John E. Levine, Stelios Kasikis, Matthias Wölfl, Daniela Weber, Elizabeth O. Hexner, Hannah Choe, Isha Gandhi, George Morales, Francis Ayuk, Wolf Rösler, Zachariah DeFilipp, Pietro Merli, Nora Rebeka Javorniczky, James L.M. Ferrara, Elisabeth Meedt, Makda Getachew Zewde, Chantiya Chanswangphuwana
Publikováno v:
Transplant Cell Ther
Acute graft-versus-host disease (GVHD) is a major cause of mortality in patients undergoing hematopoietic cell transplantation (HCT) for hematologic malignancies. The skin is the most commonly involved organ in GVHD. Elafin, a protease inhibitor over
Autor:
Isha Gandhi, Francis Ayuk, Steven Kowalyk, William J. Hogan, Janna Baez, Ran Reshef, Aaron Etra, Yi-Bin Chen, Makda Getachew Zewde, Gregory A. Yanik, Pietro Merli, Rebeka Javorniczky, John E. Levine, Paibel Aguayo-Hiraldo, Wolf Roesler, Chantiya Chanswangphuwana, Stephan A. Grupp, Tal Schechter-Finkelstein, Muna Qayed, Ryotaro Nakamura, Daniela Weber, Zachariah DeFilipp, Elizabeth O. Hexner, Stelios Kasikis, Elisabeth Meedt, Matthias Wölfl, Umut Ozbek, James L.M. Ferrara, George Morales, Hannah Choe, Carrie L. Kitko, Rachel Young
Publikováno v:
Blood. 138:3900-3900
Background: A major cause of mortality in patients receiving hematopoietic stem cell transplantation (HCT) is acute graft-versus-host disease (GVHD), a multiorgan disorder that includes the skin, liver and gastrointestinal tract. We have previously i
Autor:
Julie Ritchey, Ravi Vij, Matthew Holt, Justin King, Danny Kohnen, John F. DiPersio, Michael H. Tomasson, Julie O'Neal, Deep Hathi, Monica Shokeen, Walter J. Akers, Chantiya Chanswangphuwana, Michael P. Rettig
Publikováno v:
Blood. 128:2056-2056
Background: The interaction of multiple myeloma (MM) cells with their microenvironment in the bone marrow (BM) affects disease progression and provides resistance to therapeutic agents. Very-late-antigen 4 (VLA-4, α4β1 integrin, CD49d/CD29) is a no
Autor:
Rainer Ordemann, Madan Jagasia, John E. Levine, Yvonne A. Efebera, Chantiya Chanswangphuwana, Udomsak Bunworasate, Francis Ayuk, Steven A. Goldstein, Stephan Mielke, Steven M. Devine, Rachel Young, Anne S. Renteria, Mark R. Litzow, Zhanna Shekhovtsova, Muna Qayed, David L. Porter, Ernst Holler, Yi-Bin Chen, Franco Locatelli, William J. Hogan, James L.M. Ferrara, Andrew C. Harris, Matthias Wölfl, Tal Schechter, Ran Reshef
Publikováno v:
Blood. 126:3154-3154
Clinical GVHD staging varies between centers and is not agreed upon by independent reviewers (Weisdorf, BBMT 2003). These inconsistencies help explain why promising GVHD treatments from single center studies have not reproduced in multicenter trials.
Autor:
Noppacharn Uaprasert, Benjaporn Akkawat, Rattaporn Vichitratchaneekorn, Ponlapat Rojnuckarin, Chantiya Chanswangphuwana
Publikováno v:
Blood. 126:3256-3256
Background: Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin administration. Diagnosis of HIT is a clinical challenge. The 4Ts scoring model (0-3 low, 4-5 intermediate, 6-8 high probability of HIT) has been validated in sev